20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with uridine triphosphate in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (uridine triphosphate) | Trials (uridine triphosphate) | Recent Studies (post-2010) (uridine triphosphate) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 2,423 | 20 | 331 |
| Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | uridine triphosphate (IC50) |
|---|---|---|---|
| P2Y purinoceptor 2 | Mus musculus (house mouse) | 1.51 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bondlela, M; Falck, JR; Imig, JD; Inscho, EW; Zhao, X | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and uridine triphosphate
| Article | Year |
|---|---|
The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction.
Topics: Adenosine Triphosphate; Amides; Animals; Arterioles; Aryl Hydrocarbon Hydroxylases; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Male; Muscle, Smooth, Vascular; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y1; Renal Artery; Sulfones; Uridine Triphosphate; Vasoconstriction | 2001 |